Market Cap 972.91M
Revenue (ttm) 796.85M
Net Income (ttm) 30.44M
EPS (ttm) N/A
PE Ratio 18.25
Forward PE 19.15
Profit Margin 3.82%
Debt to Equity Ratio 0.78
Volume 1,374,100
Avg Vol 1,894,528
Day's Range N/A - N/A
Shares Out 342.57M
Stochastic %K 58%
Beta 1.54
Analysts Sell
Price Target $3.10

Company Profile

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealt...

Industry: Health Information Services
Sector: Healthcare
Phone: 855 268 2822
Address:
2701 Olympic Boulevard, Santa Monica, United States
bigd1
bigd1 May. 13 at 4:35 PM
$GDRX fuck it im doin it - try to connect with Wendy on linkedin and ask her to unload the rest of her buyback authority left in one massive trade blow up shorts
0 · Reply
bigd1
bigd1 May. 13 at 4:08 PM
$GDRX look at the revenue growth rate on the pharma direct line item vs the decline rate of legacy biz - roll those out into perpetuity and what do you get for total rev?
0 · Reply
Yayomamon
Yayomamon May. 13 at 3:00 PM
$GDRX honestly only thing to do now is hold and pray Wendy fucked is she belongs in prison hopefully company doesn’t go bankrupt we’re down 90% over the last 5 years crazy to think no one made money here during that time
0 · Reply
Yayomamon
Yayomamon May. 13 at 2:26 PM
$GDRX might be screwed here we have no volume no good news lately Wendy failed the stock holders fuck that bitch
1 · Reply
bigd1
bigd1 May. 13 at 1:41 PM
$GDRX https://stocks.apple.com/ANGzQ9fH1RAyYf3g-gExlHA
0 · Reply
bigd1
bigd1 May. 13 at 12:20 PM
$GDRX https://stockstory.org/us/stocks/nasdaq/gdrx/news/earnings-call/the-5-most-interesting-analyst-questions-from-goodrxs-q1-earnings-call
0 · Reply
bigd1
bigd1 May. 12 at 11:44 PM
$O set the nuke off on $GDRX on Jim Cramer got a slot for next week I’ve got you guys covered
0 · Reply
bigd1
bigd1 May. 12 at 11:36 PM
$GDRX the extreme losses are over its upside from here on out shut up AI stonk news
1 · Reply
topstockalerts
topstockalerts May. 12 at 11:33 PM
Jim Cramer’s “Mad Money” lightning round leaned cautiously bullish on select industrial and energy names, while being more disciplined on recent big winners. On Chevron, he was firmly positive, telling a caller they are “absolutely right” to consider buying it. He highlighted the company’s strong fundamentals, especially its robust free cash flow and a dividend yield of about 3.8%. He also pointed out that even though oil prices are at similar levels to past periods when Chevron traded higher, the stock still offers value thanks to its balance sheet strength and shareholder returns. His bottom line was clear: “pull the trigger,” reinforcing a buy stance. With GoodRx, his tone was much more cautious. He described it as a speculative investment with “limited downside,” but emphasized the inherent risk, essentially warning that investors should only approach it if they are comfortable with the possibility of extreme losses. $CVX $GDRX $VRT $STRL
0 · Reply
bigd1
bigd1 May. 12 at 11:23 PM
$GDRX moving after hours
0 · Reply
Latest News on GDRX
GoodRx price target raised to $4 from $3 at TD Cowen

2026-05-11T14:25:10.000Z - 2 days ago

GoodRx price target raised to $4 from $3 at TD Cowen


Big Pharma Runs Its Checkout Counter Through GoodRx

May 7, 2026, 1:08 PM EDT - 5 days ago

Big Pharma Runs Its Checkout Counter Through GoodRx


GoodRx Holdings Earnings Call Transcript: Q1 2026

May 7, 2026, 8:00 AM EDT - 6 days ago

GoodRx Holdings Earnings Call Transcript: Q1 2026


GoodRx Reports First Quarter 2026 Results

May 6, 2026, 4:05 PM EDT - 6 days ago

GoodRx Reports First Quarter 2026 Results


GoodRx offers Ozempic pill for Type 2 diabetes

2026-05-01T13:29:43.000Z - 12 days ago

GoodRx offers Ozempic pill for Type 2 diabetes

NVO


GoodRx price target lowered to $3.50 from $7 at Wells Fargo

2026-03-04T11:47:25.000Z - 2 months ago

GoodRx price target lowered to $3.50 from $7 at Wells Fargo


GoodRx price target lowered to $3.50 from $7 at Wells Fargo

2026-03-03T18:55:37.000Z - 2 months ago

GoodRx price target lowered to $3.50 from $7 at Wells Fargo


GoodRx price target lowered to $3.50 from $4.50 at Citi

2026-03-03T11:26:49.000Z - 2 months ago

GoodRx price target lowered to $3.50 from $4.50 at Citi


GoodRx price target lowered to $2.50 from $4 at Goldman Sachs

2026-03-02T11:36:09.000Z - 2 months ago

GoodRx price target lowered to $2.50 from $4 at Goldman Sachs


GoodRx price target lowered to $3 from $6 at Deutsche Bank

2026-02-27T14:42:12.000Z - 2 months ago

GoodRx price target lowered to $3 from $6 at Deutsche Bank


GoodRx price target lowered to $3 from $6 at TD Cowen

2026-02-27T13:52:20.000Z - 2 months ago

GoodRx price target lowered to $3 from $6 at TD Cowen


GoodRx price target lowered to $2 from $4 at UBS

2026-02-27T13:38:01.000Z - 2 months ago

GoodRx price target lowered to $2 from $4 at UBS


GoodRx price target lowered to $2 from $4 at UBS

2026-02-27T13:29:24.000Z - 2 months ago

GoodRx price target lowered to $2 from $4 at UBS


GoodRx price target lowered to $3 from $4 at Mizuho

2026-02-27T12:49:10.000Z - 2 months ago

GoodRx price target lowered to $3 from $4 at Mizuho


GoodRx Holdings Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:00 AM EST - 2 months ago

GoodRx Holdings Earnings Call Transcript: Q4 2025


GoodRx Reports Fourth Quarter and Full Year 2025 Results

Feb 25, 2026, 4:05 PM EST - 2 months ago

GoodRx Reports Fourth Quarter and Full Year 2025 Results


GoodRx Powers Pricing for Leading Brand Medications on TrumpRx

Feb 5, 2026, 7:44 PM EST - 3 months ago

GoodRx Powers Pricing for Leading Brand Medications on TrumpRx


GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies

Jan 8, 2026, 9:00 AM EST - 4 months ago

GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies


GoodRx Holdings Earnings Call Transcript: Q3 2025

Nov 5, 2025, 8:00 AM EST - 6 months ago

GoodRx Holdings Earnings Call Transcript: Q3 2025


GoodRx Reports Third Quarter 2025 Results

Nov 4, 2025, 4:05 PM EST - 6 months ago

GoodRx Reports Third Quarter 2025 Results


Should You Buy GoodRx Stock?

Nov 4, 2025, 9:55 AM EST - 6 months ago

Should You Buy GoodRx Stock?


GoodRx Teams With Kroger on Prescription Savings

Oct 1, 2025, 5:17 PM EDT - 7 months ago

GoodRx Teams With Kroger on Prescription Savings

KR


Is Novo Nordisk deal the much-needed catalyst for Goodrx stock?

Aug 18, 2025, 3:47 PM EDT - 9 months ago

Is Novo Nordisk deal the much-needed catalyst for Goodrx stock?

NVO


Novo Cuts Price of Ozempic in Half for Cash Buyers

Aug 18, 2025, 10:29 AM EDT - 9 months ago

Novo Cuts Price of Ozempic in Half for Cash Buyers

NVO


GoodRx Holdings Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 9 months ago

GoodRx Holdings Earnings Call Transcript: Q2 2025


GoodRx Reports Second Quarter 2025 Results

Aug 6, 2025, 4:05 PM EDT - 9 months ago

GoodRx Reports Second Quarter 2025 Results


GoodRx Holdings Earnings Call Transcript: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

GoodRx Holdings Earnings Call Transcript: Q1 2025


GoodRx Reports First Quarter 2025 Results

May 7, 2025, 4:13 PM EDT - 1 year ago

GoodRx Reports First Quarter 2025 Results


GoodRx Launches eCommerce Offering for Retail Pharmacies

Apr 3, 2025, 2:02 PM EDT - 1 year ago

GoodRx Launches eCommerce Offering for Retail Pharmacies


GoodRx Holdings Earnings Call Transcript: Q4 2024

Feb 27, 2025, 8:00 AM EST - 1 year ago

GoodRx Holdings Earnings Call Transcript: Q4 2024


GoodRx Reports Fourth Quarter and Full Year 2024 Results

Feb 27, 2025, 6:05 AM EST - 1 year ago

GoodRx Reports Fourth Quarter and Full Year 2024 Results


bigd1
bigd1 May. 13 at 4:35 PM
$GDRX fuck it im doin it - try to connect with Wendy on linkedin and ask her to unload the rest of her buyback authority left in one massive trade blow up shorts
0 · Reply
bigd1
bigd1 May. 13 at 4:08 PM
$GDRX look at the revenue growth rate on the pharma direct line item vs the decline rate of legacy biz - roll those out into perpetuity and what do you get for total rev?
0 · Reply
Yayomamon
Yayomamon May. 13 at 3:00 PM
$GDRX honestly only thing to do now is hold and pray Wendy fucked is she belongs in prison hopefully company doesn’t go bankrupt we’re down 90% over the last 5 years crazy to think no one made money here during that time
0 · Reply
Yayomamon
Yayomamon May. 13 at 2:26 PM
$GDRX might be screwed here we have no volume no good news lately Wendy failed the stock holders fuck that bitch
1 · Reply
bigd1
bigd1 May. 13 at 1:41 PM
$GDRX https://stocks.apple.com/ANGzQ9fH1RAyYf3g-gExlHA
0 · Reply
bigd1
bigd1 May. 13 at 12:20 PM
$GDRX https://stockstory.org/us/stocks/nasdaq/gdrx/news/earnings-call/the-5-most-interesting-analyst-questions-from-goodrxs-q1-earnings-call
0 · Reply
bigd1
bigd1 May. 12 at 11:44 PM
$O set the nuke off on $GDRX on Jim Cramer got a slot for next week I’ve got you guys covered
0 · Reply
bigd1
bigd1 May. 12 at 11:36 PM
$GDRX the extreme losses are over its upside from here on out shut up AI stonk news
1 · Reply
topstockalerts
topstockalerts May. 12 at 11:33 PM
Jim Cramer’s “Mad Money” lightning round leaned cautiously bullish on select industrial and energy names, while being more disciplined on recent big winners. On Chevron, he was firmly positive, telling a caller they are “absolutely right” to consider buying it. He highlighted the company’s strong fundamentals, especially its robust free cash flow and a dividend yield of about 3.8%. He also pointed out that even though oil prices are at similar levels to past periods when Chevron traded higher, the stock still offers value thanks to its balance sheet strength and shareholder returns. His bottom line was clear: “pull the trigger,” reinforcing a buy stance. With GoodRx, his tone was much more cautious. He described it as a speculative investment with “limited downside,” but emphasized the inherent risk, essentially warning that investors should only approach it if they are comfortable with the possibility of extreme losses. $CVX $GDRX $VRT $STRL
0 · Reply
bigd1
bigd1 May. 12 at 11:23 PM
$GDRX moving after hours
0 · Reply
bigd1
bigd1 May. 12 at 10:54 PM
$GDRX cramer green light
0 · Reply
bigd1
bigd1 May. 12 at 9:48 PM
$GDRX https://youtu.be/6K-W_z97zhU?si=HVrk5265W0MszrLa
0 · Reply
bigd1
bigd1 May. 12 at 3:10 PM
$GDRX we got $GDRX tonight and $O next week Jim Cramer Big Boss has the warhead loaded https://youtu.be/H-uANhUuCnA?si=imUqKdXz4kVZX3t5
0 · Reply
Yayomamon
Yayomamon May. 12 at 2:37 PM
$GDRX wtf happened Wendy do something
1 · Reply
bigd1
bigd1 May. 11 at 11:17 PM
$GDRX https://www.tipranks.com/news/the-fly/goodrx-price-target-raised-to-4-from-3-at-td-cowen-thefly-news Charles at TD Cowan knows the deal
0 · Reply
bigd1
bigd1 May. 11 at 10:43 PM
$GDRX god i got moved to tomorrow they timed me out for todays episode
0 · Reply
bigd1
bigd1 May. 11 at 7:29 PM
$GDRX im serious tho im not kidding - you gotta beat it out of em sometimes cuz even when they lose they wont leave the table
0 · Reply
bigd1
bigd1 May. 11 at 6:51 PM
$GDRX just got the call - will be chirping up GDRX on Jim Kramer tonight 7pm EST
0 · Reply
JPC30
JPC30 May. 11 at 5:45 PM
$GDRX Back testing 52 moving day ave
0 · Reply
Yayomamon
Yayomamon May. 11 at 3:07 PM
$GDRX stock is up 35% in the last month but I’m still down 40% 🥹🥹
0 · Reply
bigd1
bigd1 May. 11 at 3:06 PM
$GDRX price is officially just being held down by firms trying to unwind short positions inefficient market hypothesis
0 · Reply
bigd1
bigd1 May. 11 at 2:20 PM
$GDRX https://youtu.be/n0mfD4bYDBs?si=46xwdZOOSae03JxP
0 · Reply